A bullish breakout is imminent on Oxford Biomedica
By
Azeez Mustapha
PUBLISHED:
06 May 2017 @ 11:58
|
Comments (0)
|
More info about Azeez Mustapha
A bullish breakout is imminent on Oxford BiomedicaA bullish breakout is imminent on Oxford Biomedica shares (LSE:OXB). Price went bullish from January to March, 2017, and went choppy in April. Right now, price is attempting to make some bullish effort.
The market has oscillated between the upper and lower Trendlines, and it would soon close above the upper Trendline, as suggested by the RSI period 14, which is slightly above the level 50. The market would soon resume its recent bullish journey, going further upwards.
A close below the lower Trendline would render this outlook ineffectual, especially when price goes further south.
On the upside, Oxford Biomedica should test the resistance lines at 5.5, 6.5, 7.5 and 8.5, within the next several months.
Traders’ Mindset: Traders’ Mindset
CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).
This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.